We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.13B
AUM Growth
+$180M
Cap. Flow
+$94.7M
Cap. Flow %
8.35%
Top 10 Hldgs %
56.52%
Holding
45
New
11
Increased
9
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$47.9M
2
MRK icon
Merck
MRK
+$47.4M
3
UNH icon
UnitedHealth
UNH
+$46.7M
4
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$28.3M
5
EW icon
Edwards Lifesciences
EW
+$23.7M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$39.1M
2
MAKO
MAKO SURGICAL CORP COM
MAKO
+$35.4M
3
GIVN
GIVEN IMAGING LTD
GIVN
+$28.8M
4
AZN icon
AstraZeneca
AZN
+$26M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 85.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$90.2M 7.95%
2,250,000
+250,000
+13% +$9.84M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.4B
$80.2M 7.07%
2,000,000
– –
VTRS icon
3
Viatris
VTRS
$20.8B
$76M 6.7%
1,750,000
-150,000
-8% -$6.17M
ELV icon
4
Elevance Health
ELV
$81.5B
$73.9M 6.52%
800,000
-50,000
-6% -$4.44M
HCA icon
5
HCA Healthcare
HCA
$88.4B
$59.6M 5.26%
1,250,000
+500,000
+67% +$23.1M
CNMD icon
6
CONMED
CNMD
$1.3B
$58.9M 5.19%
1,385,000
+385,000
+39% +$14.6M
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$52.3M 4.61%
1,000,000
+250,000
+33% +$11.9M
VOLC
8
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$51.3M 4.53%
2,350,000
+375,000
+19% +$8.31M
MRK icon
9
Merck
MRK
$322B
$49.6M 4.37%
+1,037,834
New +$47.4M
UNH icon
10
UnitedHealth
UNH
$382B
$48.9M 4.32%
+650,000
New +$46.7M
THC icon
11
Tenet Healthcare
THC
$22.2B
$46.3M 4.09%
+1,100,000
New +$47.9M
DGX icon
12
Quest Diagnostics
DGX
$26B
$42.8M 3.78%
800,000
– –
MASI
13
DELISTED
Masimo
MASI
$41.7M 3.67%
1,425,000
-325,000
-19% -$9.1M
HUM icon
14
Humana
HUM
$43.9B
$41.3M 3.64%
400,000
– –
ARIA
15
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$35.8M 3.16%
+5,250,000
New +$28.3M
HOLX
16
DELISTED
Hologic
HOLX
$33.5M 2.96%
1,500,000
-750,000
-33% -$16.5M
A icon
17
Agilent Technologies
A
$39.6B
$28.6M 2.52%
699,000
– –
EW icon
18
Edwards Lifesciences
EW
$49.4B
$23M 2.03%
+2,100,000
New +$23.7M
CYH icon
19
Community Health Systems
CYH
$382M
$19.6M 1.73%
+605,000
New +$20.8M
UAM
20
DELISTED
Universal American Corp
UAM
$18.3M 1.61%
2,500,000
+1,829,400
+273% +$13.7M
NVAX icon
21
Novavax
NVAX
$1.21B
$17.9M 1.58%
175,000
-60,550
-26% -$4.28M
ANGO icon
22
AngioDynamics
ANGO
$605M
$17.2M 1.52%
1,000,000
-327,500
-25% -$5.04M
AMRN
23
Amarin Corp
AMRN
$297M
$16.7M 1.48%
+425,000
New +$22M
ARWR icon
24
Arrowhead Research
ARWR
$12.1B
$16.3M 1.44%
1,500,000
-999,999
-40% -$7.99M
CCRN
25
DELISTED
Cross Country Healthcare
CCRN
$15.4M 1.36%
1,540,000
– –
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Camber Capital Management held 45 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Camber Capital Management deployed $94.7M of net new capital in Q4 2013, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was Tenet Healthcare: 1,100,000 shares worth $46.3M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 78% a quarter earlier.

On the sell side, the largest reduction was Hologic, an estimated $16.5M trimmed.

  • Camber Capital Management's largest Q4 2013 buy was Tenet Healthcare: 1,100,000 shares worth $46.3M.
  • Camber Capital Management added most to HCA Healthcare in Q4 2013, an estimated $23.1M increase.
  • Camber Capital Management's biggest Q4 2013 reduction was Hologic, cutting an estimated $16.5M.
  • Camber Capital Management fully exited Cardinal Health in Q4 2013, selling an estimated $39.1M.
  • Camber Capital Management's ten largest holdings make up 57% of its $1.13B portfolio in Q4 2013.
  • Camber Capital Management opened 11 new positions and closed 9 in Q4 2013.
  • Camber Capital Management's portfolio value rose 19% quarter-over-quarter to $1.13B.

Based on Camber Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.